Marine Drugs

Show Articles
Journal Properties
  • Country
    Switzerland
  • Language
    English
  • Number of Articles
    6,638
  • Abbreviation
    Mar Drugs
  • e-ISSN
    1660-3397
  • Main Publisher
    Multidisciplinary Digital Publishing Institute (MDPI)
  • Publisher
    MDPI AG
  • Indian UGC
  • DOAJ (latest)
Journal Properties
  • Final Decision (day)
    42
  • Medicine
    Public aspects of medicine
    Toxicology
    Poisons
    Medicine
    Therapeutics
    Pharmacology
    Science
    Biology (General)
  • website
Description
Marine Drugs is a peer-reviewed, open access journal dedicated to the discovery, development, and pharmacology of marine-derived compounds. It explores the potential of marine organisms as sources of novel therapeutic agents. Targeting researchers in pharmacology, chemistry, and marine biology, the journal emphasizes the isolation, characterization, and biological activities of marine natural products. Key topics include anti-cancer agents, antimicrobials, antivirals, and anti-inflammatory compounds derived from marine sources. It covers research on drug delivery systems for marine-derived drugs, toxicity studies, and the sustainable sourcing of marine resources. The journal is indexed in major databases, including Web of Science and Scopus, ensuring wide visibility. Researchers are encouraged to submit original research articles, reviews, and short communications. By publishing high-quality research, Marine Drugs aims to accelerate the development of innovative therapies from the ocean, contributing to improved human health and pharmaceutical advancements. Its open access format ensures that valuable findings are readily available to the global scientific community.
Directory of Open Access Journals (DOAJ)
There is further information about this journal. Please follow links.